PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsMajor depressive disorder
MeSH D003865 - major depressive disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003866:Depressive disorder
164 Companies
36 Drugs
$
Success rate
D003865: 
Major depressive disorder
79 Companies
13 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieLevomilnacipran Fetzima 2026-01-11 2013-07-25   
Escitalopram oxalate Lexapro  2002-08-14   
Milnacipran Savella 2023-01-14 2009-01-14   
Vilazodone Viibryd  2011-01-21   
Accord HealthcareEscitalopram oxalate Escitalopram Oxalate  2012-09-11   
Fluoxetine Fluoxetine  2020-08-27   
Lurasidone Lurasidone  2019-01-03   
Quetiapine Quetiapine  2016-11-01   
Vilazodone Vilazodone  2021-04-27   
ACRAFLurasidone Latuda  2014-03-21   
Ajanta PharmaDuloxetine Duloxetine  2017-01-06   
Brexpiprazole Brexpiprazole  2023-02-03   
Alembic PharmaceuticalsDesvenlafaxine Desvenlafaxine  2015-06-29   
Duloxetine Duloxetine  2014-06-09   
Fluoxetine Fluoxetine  2009-03-19   
Lurasidone Lurasidone  2021-05-13   
Quetiapine Quetiapine  2014-10-28   
Vilazodone Vilazodone  2020-01-10   
Alkem LaboratoriesDuloxetine Duloxetine  2015-08-26   
Quetiapine Quetiapine  2013-02-12   
Lurasidone Lurasidone  2022-12-13   
Brexpiprazole Brexpiprazole  2023-11-28   
AllerganFluoxetine Sarafem  2006-05-19   
Desvenlafaxine Desvenlafaxine  2016-07-29   
Duloxetine Duloxetine  2013-12-17   
Fluoxetine Fluoxetine  2002-01-29   
Lurasidone Lurasidone  2021-02-02   
Quetiapine Quetiapine  2013-02-27   
Amneal PharmaceuticalsEscitalopram oxalate Escitalopram Oxalate  2012-03-14   
Levomilnacipran Levomilnacipran  2019-02-04   
Lurasidone Lurasidone  2019-01-03   
Milnacipran Milnacipran  2016-04-22   
Quetiapine Quetiapine  2018-10-26   
Brexpiprazole Brexpiprazole  2023-01-31   
ANDA RepositoryBrexpiprazole Brexpiprazole  2023-10-25   
ANI PharmaceuticalsFluoxetine Fluoxetine  2008-05-20   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
72%
65/90
Phase 2
60%
76/127
Phase 3
56%
54/96
Approved: 14Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Escitalopram oxalate,
Levomilnacipran,
Milnacipran,
Ademetionine,
Adt
Allergan
Fluoxetine,
Rapastinel,
Ademetionine,
Sodium chloride,
APIMOSTINEL,
Nmda,
Ssri,
Azzalure,
MD05
AstraZeneca
Quetiapine,
Benzodiazepine,
Escitalopram,
Dexmecamylamine,
Glutamic acid,
Sodium chloride,
Aspartame,
LANICEMINE,
D-glutamate,
AZD7268,
Gladem,
Azd2327,
Lexapro,
AZD2066,
Wellbutrin,
Nmda,
Ssri,
Evidence,
Zyban
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use